【Healthkoreanews】The generic drug's competition in Korean market is expected to overheat in 2009.
The Hana Daetoo securities Co., LTD.(hereinafter Hana) reports that the key issue of Korean drugmarket in 2009 will be the competition of generic drugs which has accelerated since the second half of 2008.
Jo yoon-Jung, analyst of Hana, said, "The winner of this competition will have motive power for leading the growth during next 3~5 years."
She also said, " The high ranked drugmakers now have the competitive edge over other drugmakers."
Hana expects that the generic drugs sales will be increased by 15.4% in 2009 compared with 2008.<헬스코리아뉴스>
저작권자 © 헬스코리아뉴스 무단전재 및 재배포 금지
